 | • レポートコード：MRC2-11QY13565 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は急性骨髄性白血病治療薬のグローバル市場について調査・分析したレポートです。種類別（パイプライン薬、化学療法薬、化学療法レジメン）市場規模、用途別（病院、診療所、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別急性骨髄性白血病治療薬の競争状況、市場シェア ・世界の急性骨髄性白血病治療薬市場：種類別市場規模 2015年-2020年（パイプライン薬、化学療法薬、化学療法レジメン） ・世界の急性骨髄性白血病治療薬市場：種類別市場規模予測 2021年-2026年（パイプライン薬、化学療法薬、化学療法レジメン） ・世界の急性骨髄性白血病治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、在宅ケア） ・世界の急性骨髄性白血病治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、在宅ケア） ・北米の急性骨髄性白血病治療薬市場分析：米国、カナダ ・ヨーロッパの急性骨髄性白血病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの急性骨髄性白血病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の急性骨髄性白血病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの急性骨髄性白血病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Ambit Biosciences Corporation、Genzyme Corporation Celgene Corporation、Clavis Pharma ASA、Sunesis Pharmaceuticals、Cephalon、Bristol-Myers Squibb、Novartis International AG、GlaxoSmithKline ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age. Incidence rate of acute myeloid leukemia is high in men and women over 50 years.
Geographically, acute myeloid leukemia therapeutics market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. As of 2014, North America held substantial share of the acute myeloid leukemia therapeutics market owing to prominent growth factors including rising incidences of acute myeloid leukemia and increasing geriatric population. Furthermore, advanced healthcare infrastructure, rising need of targeted therapies, huge investment in the development of pipeline drugs, and awareness amongst the population base induced market growth in this region. Asia Pacific is expected to be the fastest growing region over the forecast period owing to growth factors such as rising investments, rising disposable incomes, increasing cancer awareness, and improving healthcare infrastructure. Additionally, increasing inclination towards therapies such as targeted therapies resulting in low collateral damage and stronger efficacy is also anticipated to propel the demand for the acute myeloid leukemia therapeutics market in this region.
Market Analysis and Insights: Global Acute Myeloid Leukemia Therapeutics Market
The global Acute Myeloid Leukemia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Acute Myeloid Leukemia Therapeutics Scope and Market Size
Acute Myeloid Leukemia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Myeloid Leukemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Ambit Biosciences Corporation
Genzyme Corporation Celgene Corporation
Clavis Pharma ASA
Sunesis Pharmaceuticals
Cephalon
Bristol-Myers Squibb
Novartis International AG
GlaxoSmithKline
Market segment by Type, the product can be split into
Pipeline Drugs
Chemotherapy Drugs
Chemotherapy Regimens
Market segment by Application, split into
Hospitals
Clinics
Home Care
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Myeloid Leukemia Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Pipeline Drugs
1.4.3 Chemotherapy Drugs
1.4.4 Chemotherapy Regimens
1.5 Market by Application
1.5.1 Global Acute Myeloid Leukemia Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Acute Myeloid Leukemia Therapeutics Market Perspective (2015-2026)
2.2 Global Acute Myeloid Leukemia Therapeutics Growth Trends by Regions
2.2.1 Acute Myeloid Leukemia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Myeloid Leukemia Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acute Myeloid Leukemia Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Myeloid Leukemia Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Acute Myeloid Leukemia Therapeutics Players by Market Size
3.1.1 Global Top Acute Myeloid Leukemia Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Myeloid Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio
3.2.1 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Therapeutics Revenue in 2019
3.3 Acute Myeloid Leukemia Therapeutics Key Players Head office and Area Served
3.4 Key Players Acute Myeloid Leukemia Therapeutics Product Solution and Service
3.5 Date of Enter into Acute Myeloid Leukemia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Acute Myeloid Leukemia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)
5.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
6.2 Acute Myeloid Leukemia Therapeutics Key Players in North America (2019-2020)
6.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
6.4 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
7.2 Acute Myeloid Leukemia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
8.2 Acute Myeloid Leukemia Therapeutics Key Players in China (2019-2020)
8.3 China Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
8.4 China Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
9.2 Acute Myeloid Leukemia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
10.2 Acute Myeloid Leukemia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
11.2 Acute Myeloid Leukemia Therapeutics Key Players in India (2019-2020)
11.3 India Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
11.4 India Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
12.2 Acute Myeloid Leukemia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Ambit Biosciences Corporation
13.1.1 Ambit Biosciences Corporation Company Details
13.1.2 Ambit Biosciences Corporation Business Overview
13.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Introduction
13.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020))
13.1.5 Ambit Biosciences Corporation Recent Development
13.2 Genzyme Corporation Celgene Corporation
13.2.1 Genzyme Corporation Celgene Corporation Company Details
13.2.2 Genzyme Corporation Celgene Corporation Business Overview
13.2.3 Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Introduction
13.2.4 Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
13.2.5 Genzyme Corporation Celgene Corporation Recent Development
13.3 Clavis Pharma ASA
13.3.1 Clavis Pharma ASA Company Details
13.3.2 Clavis Pharma ASA Business Overview
13.3.3 Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Introduction
13.3.4 Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
13.3.5 Clavis Pharma ASA Recent Development
13.4 Sunesis Pharmaceuticals
13.4.1 Sunesis Pharmaceuticals Company Details
13.4.2 Sunesis Pharmaceuticals Business Overview
13.4.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Introduction
13.4.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
13.4.5 Sunesis Pharmaceuticals Recent Development
13.5 Cephalon
13.5.1 Cephalon Company Details
13.5.2 Cephalon Business Overview
13.5.3 Cephalon Acute Myeloid Leukemia Therapeutics Introduction
13.5.4 Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
13.5.5 Cephalon Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview
13.6.3 Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Introduction
13.6.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Novartis International AG
13.7.1 Novartis International AG Company Details
13.7.2 Novartis International AG Business Overview
13.7.3 Novartis International AG Acute Myeloid Leukemia Therapeutics Introduction
13.7.4 Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
13.7.5 Novartis International AG Recent Development
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Details
13.8.2 GlaxoSmithKline Business Overview
13.8.3 GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Introduction
13.8.4 GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
13.8.5 GlaxoSmithKline Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Acute Myeloid Leukemia Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Myeloid Leukemia Therapeutics Revenue
Table 3. Ranking of Global Top Acute Myeloid Leukemia Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pipeline Drugs
Table 6. Key Players of Chemotherapy Drugs
Table 7. Key Players of Chemotherapy Regimens
Table 8. Global Acute Myeloid Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Acute Myeloid Leukemia Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Acute Myeloid Leukemia Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Acute Myeloid Leukemia Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Acute Myeloid Leukemia Therapeutics Players
Table 19. Global Acute Myeloid Leukemia Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Acute Myeloid Leukemia Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Acute Myeloid Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Therapeutics as of 2019)
Table 22. Global Acute Myeloid Leukemia Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Acute Myeloid Leukemia Therapeutics Product Solution and Service
Table 25. Date of Enter into Acute Myeloid Leukemia Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Acute Myeloid Leukemia Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Acute Myeloid Leukemia Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Acute Myeloid Leukemia Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Acute Myeloid Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Acute Myeloid Leukemia Therapeutics Market Share (2019-2020)
Table 35. North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Acute Myeloid Leukemia Therapeutics Market Share by Type (2015-2020)
Table 37. North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Acute Myeloid Leukemia Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Acute Myeloid Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Acute Myeloid Leukemia Therapeutics Market Share (2019-2020)
Table 41. Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Acute Myeloid Leukemia Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Acute Myeloid Leukemia Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Acute Myeloid Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Acute Myeloid Leukemia Therapeutics Market Share (2019-2020)
Table 47. China Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Acute Myeloid Leukemia Therapeutics Market Share by Type (2015-2020)
Table 49. China Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Acute Myeloid Leukemia Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Acute Myeloid Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Acute Myeloid Leukemia Therapeutics Market Share (2019-2020)
Table 53. Japan Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Acute Myeloid Leukemia Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Acute Myeloid Leukemia Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Acute Myeloid Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Acute Myeloid Leukemia Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Acute Myeloid Leukemia Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Acute Myeloid Leukemia Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Acute Myeloid Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Acute Myeloid Leukemia Therapeutics Market Share (2019-2020)
Table 65. India Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Acute Myeloid Leukemia Therapeutics Market Share by Type (2015-2020)
Table 67. India Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Acute Myeloid Leukemia Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Acute Myeloid Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Acute Myeloid Leukemia Therapeutics Market Share (2019-2020)
Table 71. Central & South America Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Acute Myeloid Leukemia Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Acute Myeloid Leukemia Therapeutics Market Share by Application (2015-2020)
Table 75. Ambit Biosciences Corporation Company Details
Table 76. Ambit Biosciences Corporation Business Overview
Table 77. Ambit Biosciences Corporation Product
Table 78. Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 79. Ambit Biosciences Corporation Recent Development
Table 80. Genzyme Corporation Celgene Corporation Company Details
Table 81. Genzyme Corporation Celgene Corporation Business Overview
Table 82. Genzyme Corporation Celgene Corporation Product
Table 83. Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 84. Genzyme Corporation Celgene Corporation Recent Development
Table 85. Clavis Pharma ASA Company Details
Table 86. Clavis Pharma ASA Business Overview
Table 87. Clavis Pharma ASA Product
Table 88. Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 89. Clavis Pharma ASA Recent Development
Table 90. Sunesis Pharmaceuticals Company Details
Table 91. Sunesis Pharmaceuticals Business Overview
Table 92. Sunesis Pharmaceuticals Product
Table 93. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 94. Sunesis Pharmaceuticals Recent Development
Table 95. Cephalon Company Details
Table 96. Cephalon Business Overview
Table 97. Cephalon Product
Table 98. Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 99. Cephalon Recent Development
Table 100. Bristol-Myers Squibb Company Details
Table 101. Bristol-Myers Squibb Business Overview
Table 102. Bristol-Myers Squibb Product
Table 103. Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 104. Bristol-Myers Squibb Recent Development
Table 105. Novartis International AG Company Details
Table 106. Novartis International AG Business Overview
Table 107. Novartis International AG Product
Table 108. Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 109. Novartis International AG Recent Development
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline Product
Table 112. GlaxoSmithKline Company Details
Table 113. GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 114. GlaxoSmithKline Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Pipeline Drugs Features
Figure 3. Chemotherapy Drugs Features
Figure 4. Chemotherapy Regimens Features
Figure 5. Global Acute Myeloid Leukemia Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Home Care Case Studies
Figure 9. Acute Myeloid Leukemia Therapeutics Report Years Considered
Figure 10. Global Acute Myeloid Leukemia Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Acute Myeloid Leukemia Therapeutics Market Share by Players in 2019
Figure 15. Global Top Acute Myeloid Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue in 2019
Figure 17. North America Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
急性骨髄性白血病の世界市場（～2026年） Leukemia are a heterogeneous group of cancers affecting the bone marrow and White Blood Cells (WBC). Leukemia is characterized by the rapid increase of abnormal blood cells growth or blasts, resulting in a decrease in the numbers of healthy, normal fully modified blood cells, leading to the typical …- 再発急性骨髄性白血病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Relapsed Acute Myeloid Leukemia Drug Market The global Relapsed Acute Myeloid Leukemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Relapsed Acute Myeloid Leukemia Drug Scop…
- 白血病の世界市場（～2026年） Leukemia is a group ofcancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. High incidence rate of blood cancers and rise in incidence of leukaemia across the globe will drive the leukemia market. Market Analysis and Insights: Global Leukemia Cancer …
- 急性リンパ芽球性白血病薬の世界市場（～2026年） Market Analysis and Insights: Global Acute Lymphoblastic Leukemia Drug Market The global Acute Lymphoblastic Leukemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Acute Lymphoblastic Leukemia Drug Scope and Mar…
- 慢性リンパ性白血病（CLL）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market size is projected to reach US$ 9390.9 million by 2026, from US$ 8411.2 million in 2020, at a CAGR of 10.8%% during 2021-2026. Global Chronic Lymphocytic L…